Anthony Kaczmarek, M.D.
Urology Physician in Rolla, Missouri.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,606 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Anthony Kaczmarek, M.D. reported a CMS MIPS final score of 40.4/100 - below the 83.5 national average - and filed 4,089 Medicare Part D claims in 2024.
- 40.4/100
- MIPS score · -43 vs avg
- 4K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥4th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Anthony Kaczmarek, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1306803754), first enumerated 04/28/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 4,089 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 40.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$48.89 in reported industry payments (3 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1306803754 · Urology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1306803754
- ENUM-LEGACY 2006
- TAX-MID 14K Urology Physician
- MIPS-LOW 40.4/100
- RX-MID 4,089
- BOOK-THIN 250 in Missouri
- PHOTO-FINISH Richard Morrow, MD · ±1.6
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- John Kefer, MD P…
John Kefer, MD PHD
38.3 MIPS pts
- John Mancini, M.…
John Mancini, M.D.
38.3 MIPS pts
- Kaczmarek · this…
Kaczmarek · this provider
40.4 MIPS pts
- Richard Morrow, …
Richard Morrow, MD
42 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Anthony Kaczmarek, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
40 ≥ 4th percentile 4% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Anthony Kaczmarek, M.D. sits
This provider among urology physician peers
Across the 4,091 urology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Anthony Kaczmarek, M.D. writes more Part D claims than 96% of them and scores higher on MIPS quality than 5% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one urology physician peer from a representative sample of 60; the gold marker is Anthony Kaczmarek, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Anthony Kaczmarek, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Anthony Kaczmarek, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Missouri
How Urology Physician compares to other specialties among Missouri providers
Urology Physician ranks #66 among Missouri's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Missouri provider total, by primary NUCC taxonomy. The highlighted bar is Urology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Anthony Kaczmarek, M.D.'s 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 40.4/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Urology Physician US NPIs
40.4/100 MIPS final score - 43.1 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Urology Physician. Quality dim: 0. Cost dim: 34.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1306803754 |
|---|---|
| Specialty | Urology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Anthony Kaczmarek, M.D.'s current license status, disciplinary history, and board certifications with the Missouri Board of Registration for the Healing Arts in Missouri before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1306803754 is the unique 10-digit identifier CMS uses to link Kaczmarek across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Anthony Kaczmarek, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$49
Largest payer
COLOPLAST CORP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 8,756.567
- Total Day Supply
- 248,640
- Generic Drug Cost
- $97K
- Opioid Claims
- 139 (3.4% rate)
- Antibiotic Claims
- 564
Patient Demographics
- Average Patient Age
- 75.5 years
- Avg HCC Risk Score
- 1.37
- Gender Split
- 27% female / 73% male
- Age Distribution
- <65: 49, 65-74: 301, 75-84: 303, 85+: 111
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Anthony Kaczmarek, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Tamsulosin Hcl
Tamsulosin Hcl
845 claims
- Finasteride
Finasteride
702 claims
- Alfuzosin Hcl Er 270
Alfuzosin Hcl Er
270 claims
- Solifenacin Succin… 269
Solifenacin Succinate
269 claims
- Methenamine Hippur… 153
Methenamine Hippurate
153 claims
- Terazosin Hcl 134
Terazosin Hcl
134 claims
- Nitrofurantoin Mon… 129
Nitrofurantoin Mono-Macro
129 claims
- Myrbetriq 111
Myrbetriq
111 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 845 |
| Finasteride | 702 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 270 |
| Solifenacin Succinate | 269 |
| Methenamine Hippurate | 153 |
| Terazosin Hcl | 134 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 129 |
| Myrbetriq Mirabegron | 111 |
| Allopurinol | 99 |
| Cephalexin | 96 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How Anthony Kaczmarek, M.D. fits within the Urology Physician landscape nationally.
Anthony Kaczmarek, M.D.'s 4,089 claims are above the specialty average of 1,354.
Nationwide Urology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Kaczmarek, both outside Missouri so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (40.4 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urology Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Kaczmarek.
One of 250 Urology Physician providers enrolled in Missouri, 5 are shown here.
Compare Urology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Anthony Kaczmarek, M.D.'s specialty? ▼
How much does Anthony Kaczmarek, M.D. prescribe under Medicare Part D? ▼
What is Anthony Kaczmarek, M.D.'s Medicare quality score? ▼
Where is Anthony Kaczmarek, M.D. located? ▼
What is Anthony Kaczmarek, M.D.'s NPI number? ▼
Does Anthony Kaczmarek, M.D. prescribe opioids? ▼
How many Urology Physician providers are there in the US? ▼
What drugs does Anthony Kaczmarek, M.D. prescribe most often? ▼
Does Anthony Kaczmarek, M.D. accept Medicare? ▼
How can I verify Anthony Kaczmarek, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.